O106 A CHEMORADIOTHERAPY TREATMENT RESPONSE MRNA SIGNATURE AS PREDICTOR FOR ESOPHAGEAL ADENOCARCINOMA TREATED ACCORDING TO THE CROSS REGIMEN
Hoefnagel, S J M, Koster, J, Koemans, W J, van Dieren, J M, van Sandick, J W, Kodach, L L, Calpe, S, Meijer, S L, del Sancho-Serra, C M, Khan, H N, Van Laarhoven, H W M, Van Berge Henegouwen, M I, Gisbertz, S S, Hulshof, M C C M, Krishnadath, K K
Published in Diseases of the esophagus (23.11.2019)
Published in Diseases of the esophagus (23.11.2019)
Get full text
Journal Article
O108 GENOMIC BIOMARKERS FOR CANCER RISK IN BARRETT’S ESOPHAGUS: AN UPDATE ON THE LONGITUDINAL DUTCH BARRETT’S ESOPHAGUS COHORT
Hoefnagel, S J M, Westra, W M, Timmer, M R, Martinez, P, Klaver, E, Lau, C T, Calpe, S, Sancho-Serra, M del C, Straub, D, Baker, A M, Rygiel, A M, Rosmolen, W D, Meijer, S L, ten Kate, F J W, Dijkgraaf, M G W, Mallant-Hent, R C, Naber, A H J, van Oijen, A H A M, Baak, L C, Scholten, P, Böhmer, C J M, Maley, C C, Graham, T A, Bergman, J J G H M, Krishnadath, K K
Published in Diseases of the esophagus (23.11.2019)
Published in Diseases of the esophagus (23.11.2019)
Get full text
Journal Article